SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22
Published December 13, 2023 · Recall initiated: November 22, 2023
Summary
FDA records drug Class I recall D-0144-2024, published December 13, 2023 and initiated November 22, 2023. Recalling firm: Novartis Pharmaceuticals Corporation; Status: Ongoing; Reported quantity: 6,997 bottles; Lot: Lot #: FX001500, FX001582, Exp. 09/30/2024. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Distributor
- Nationwide within the United States
- Lot
- Lot #: FX001500, FX001582, Exp. 09/30/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADiovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC,August 19, 2026
- FDAKinderMed INFANTS' PAIN & FEVER Acetaminophen, 160 mg per 5 mL bottles, Oral Suspension, Organic CherryDecember 13, 2023
- FDAOndansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter HealthcareDecember 13, 2023
- FDANeoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin CapsulesOctober 5, 2022
- FDAXiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2June 15, 2022
- FDAXiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2June 15, 2022
Questions about this recall
Was SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22 recalled?
Yes. FDA published recall D-0144-2024 on December 13, 2023. Reported hazard: Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals
What should I do if I have this product?
Voluntary: Firm initiated · Letter